Profile picture

Doctor Donato Cappetta

Second University of Naples, Naples (Italy)
Follow
Logo ESC

Contributor content

Dapagliflozin improves diastolic performance in an animal model of heart failure with preserved ejection fraction
Presentation
Dapagliflozin improves diastolic performance in an animal model of heart failure with preserved ejection fraction
Read more
Dipeptidyl peptidase 4 inhibitor sitagliptin ameliorates renal function in a model of hypertension-induced cardiorenal disease
Presentation
Dipeptidyl peptidase 4 inhibitor sitagliptin ameliorates renal function in a model of hypertension-induced cardiorenal disease
Read more
Dipeptidyl peptidase 4 inhibitor sitagliptin ameliorates cardio-renal axis in Dahl salt-sensitive hypertensive rat model
Presentation
Dipeptidyl peptidase 4 inhibitor sitagliptin ameliorates cardio-renal axis in Dahl salt-sensitive hypertensive rat model
Read more
Effects of SGLT2 inhibitor dapagliflozin in a non-diabetic hypertensive model of heart failure with preserved ejection fraction
Presentation
Effects of SGLT2 inhibitor dapagliflozin in a non-diabetic hypertensive model of heart failure with preserved ejection fraction
Read more
Inhibition of cardiac lymphangiogenesis in imatinib-induced cardiomyopathy
Presentation
Inhibition of cardiac lymphangiogenesis in imatinib-induced cardiomyopathy
Read more
Effects of ranolazine in a model of doxorubicin-induced left ventricle diastolic dysfunction
Presentation
Effects of ranolazine in a model of doxorubicin-induced left ventricle diastolic dysfunction
Read more
Resveratrol attenuates diastolic dysfunction by reducing cardiac fibrosis in a model of doxorubicin cardiomyopathy
Presentation
Resveratrol attenuates diastolic dysfunction by reducing cardiac fibrosis in a model of doxorubicin cardiomyopathy
Read more

ESC 365 is supported by

novartis Explore sponsored resources